{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:40:19Z","timestamp":1790775619293,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS115867"],"award-info":[{"award-number":["NS115867"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011671","name":"G. Harold and Leila Y. Mathers Foundation","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/100011671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012643","name":"Edward Mallinckrodt, Jr. Foundation","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/100012643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000910","name":"Conrad N. Hilton Foundation","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/100000910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41589-022-01115-2","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T16:03:59Z","timestamp":1661184239000},"page":"925-933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The landscape of targets and lead molecules for remyelination"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-5621","authenticated-orcid":false,"given":"Andrew V.","family":"Caprariello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-336X","authenticated-orcid":false,"given":"Drew J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"1115_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","volume":"19","author":"C Lubetzki","year":"2020","unstructured":"Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C. & Stankoff, B. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 19, 678\u2013688 (2020).","journal-title":"Lancet Neurol."},{"key":"1115_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","volume":"268","author":"N Cunniffe","year":"2021","unstructured":"Cunniffe, N. & Coles, A. Promoting remyelination in multiple sclerosis. J. Neurol. 268, 30\u201344 (2021).","journal-title":"J. Neurol."},{"key":"1115_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2009.12.020","volume":"225","author":"SP Fancy","year":"2010","unstructured":"Fancy, S. P. et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp. Neurol. 225, 18\u201323 (2010).","journal-title":"Exp. Neurol."},{"key":"1115_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","volume":"145","author":"R Hoftberger","year":"2017","unstructured":"Hoftberger, R. & Lassmann, H. Inflammatory demyelinating diseases of the central nervous system. Handb. Clin. Neurol. 145, 263\u2013283 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"1115_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200502086","volume":"169","author":"W Lin","year":"2005","unstructured":"Lin, W., Harding, H. P., Ron, D. & Popko, B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-\u03b3. J. Cell Biol. 169, 603\u2013612 (2005).","journal-title":"J. Cell Biol."},{"key":"1115_CR6","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.1523\/JNEUROSCI.3817-14.2015","volume":"35","author":"EG Baxi","year":"2015","unstructured":"Baxi, E. G. et al. Transfer of myelin-reactive Th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. J. Neurosci. 35, 8626\u20138639 (2015).","journal-title":"J. Neurosci."},{"key":"1115_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby, L. et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat. Commun. 10, 3887 (2019).","journal-title":"Nat. Commun."},{"key":"1115_CR8","doi-asserted-by":"publisher","first-page":"eabd9036","DOI":"10.1126\/sciadv.abd9036","volume":"7","author":"S Saez-Atienzar","year":"2021","unstructured":"Saez-Atienzar, S. et al. Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types. Sci Adv. 7, eabd9036 (2021).","journal-title":"Sci Adv."},{"key":"1115_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang, S. H. et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16, 571\u2013579 (2013).","journal-title":"Nat. Neurosci."},{"key":"1115_CR10","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1073\/pnas.081071198","volume":"98","author":"Y Hakak","year":"2001","unstructured":"Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA 98, 4746\u20134751 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR11","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.neuron.2021.05.012","volume":"109","author":"JF Chen","year":"2021","unstructured":"Chen, J. F. et al. Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer\u2019s disease. Neuron 109, 2292\u20132307 e2295 (2021).","journal-title":"Neuron"},{"key":"1115_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/ane.13538","volume":"145","author":"V Siokas","year":"2022","unstructured":"Siokas, V. et al. Myelin-associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson\u2019s disease. Acta Neurol. Scand. 145, 223\u2013228 (2022).","journal-title":"Acta Neurol. Scand."},{"key":"1115_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/978-1-4614-0653-2_13","volume":"724","author":"SJ Perlman","year":"2012","unstructured":"Perlman, S. J. & Mar, S. Leukodystrophies. Adv. Exp. Med Biol. 724, 154\u2013171 (2012).","journal-title":"Adv. Exp. Med Biol."},{"key":"1115_CR14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","volume":"89","author":"JL Olmos-Serrano","year":"2016","unstructured":"Olmos-Serrano, J. L. et al. Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron 89, 1208\u20131222 (2016).","journal-title":"Neuron"},{"key":"1115_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.neuron.2020.09.016","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Robust myelination of regenerated axons induced by combined manipulations of GPR17 and Microglia. Neuron 108, 876\u2013886 e874 (2020).","journal-title":"Neuron"},{"key":"1115_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.256","volume":"8","author":"E Bonfanti","year":"2017","unstructured":"Bonfanti, E. et al. The role of oligodendrocyte precursor cells expressing the GPR17 receptor in brain remodeling after stroke. Cell Death Dis. 8, e2871 (2017).","journal-title":"Cell Death Dis."},{"key":"1115_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","volume":"21","author":"SA Back","year":"2001","unstructured":"Back, S. A. et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 21, 1302\u20131312 (2001).","journal-title":"J. Neurosci."},{"key":"1115_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/glia.23245","volume":"66","author":"JR Plemel","year":"2018","unstructured":"Plemel, J. R. et al. Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy. Glia 66, 327\u2013347 (2018).","journal-title":"Glia"},{"key":"1115_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima, G. K. & Morell, P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107\u2013116 (2001).","journal-title":"Brain Pathol."},{"key":"1115_CR20","first-page":"597","volume":"39","author":"SK Ludwin","year":"1978","unstructured":"Ludwin, S. K. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest. 39, 597\u2013612 (1978).","journal-title":"Lab Invest."},{"key":"1115_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35734-4","volume":"9","author":"CR Hooijmans","year":"2019","unstructured":"Hooijmans, C. R. et al. Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. Sci. Rep. 9, 822 (2019).","journal-title":"Sci. Rep."},{"key":"1115_CR22","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1073\/pnas.0812500106","volume":"106","author":"ID Duncan","year":"2009","unstructured":"Duncan, I. D., Brower, A., Kondo, Y., Curlee, J. F. Jr. & Schultz, R. D. Extensive remyelination of the CNS leads to functional recovery. Proc. Natl Acad. Sci. USA 106, 6832\u20136836 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.23606","volume":"72","author":"AV Caprariello","year":"2012","unstructured":"Caprariello, A. V., Mangla, S., Miller, R. H. & Selkirk, S. M. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. Ann. Neurol. 72, 395\u2013405 (2012).","journal-title":"Ann. Neurol."},{"key":"1115_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nn.4193","volume":"19","author":"M Traka","year":"2016","unstructured":"Traka, M., Podojil, J. R., McCarthy, D. P., Miller, S. D. & Popko, B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat. Neurosci. 19, 65\u201374 (2016).","journal-title":"Nat. Neurosci."},{"key":"1115_CR25","doi-asserted-by":"publisher","unstructured":"Glatigny, S. & Bettelli, E. Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS). Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a028977 (2018).","DOI":"10.1101\/cshperspect.a028977"},{"key":"1115_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/dbio.1999.9466","volume":"216","author":"S Robinson","year":"1999","unstructured":"Robinson, S. & Miller, R. H. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 216, 359\u2013368 (1999).","journal-title":"Dev. Biol."},{"key":"1115_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","volume":"26","author":"MR Kotter","year":"2006","unstructured":"Kotter, M. R., Li, W. W., Zhao, C. & Franklin, R. J. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26, 328\u2013332 (2006).","journal-title":"J. Neurosci."},{"key":"1115_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/exnr.1999.7224","volume":"160","author":"JM Levine","year":"1999","unstructured":"Levine, J. M. & Reynolds, R. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp. Neurol. 160, 333\u2013347 (1999).","journal-title":"Exp. Neurol."},{"key":"1115_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/glia.20480","volume":"55","author":"Z Wang","year":"2007","unstructured":"Wang, Z., Colognato, H. & Ffrench-Constant, C. Contrasting effects of mitogenic growth factors on myelination in neuron-oligodendrocyte co-cultures. Glia 55, 537\u2013545 (2007).","journal-title":"Glia"},{"key":"1115_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.devcel.2015.06.011","volume":"34","author":"JB Zuchero","year":"2015","unstructured":"Zuchero, J. B. et al. CNS myelin wrapping is driven by actin disassembly. Dev. Cell 34, 152\u2013167 (2015).","journal-title":"Dev. Cell"},{"key":"1115_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1","volume":"58","author":"RJ Franklin","year":"1999","unstructured":"Franklin, R. J. & Hinks, G. L. Understanding CNS remyelination: clues from developmental and regeneration biology. J. Neurosci. Res. 58, 207\u2013213 (1999).","journal-title":"J. Neurosci. Res."},{"key":"1115_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-neuro-061010-113629","volume":"34","author":"SP Fancy","year":"2011","unstructured":"Fancy, S. P., Chan, J. R., Baranzini, S. E., Franklin, R. J. & Rowitch, D. H. Myelin regeneration: a recapitulation of development. Annu Rev. Neurosci. 34, 21\u201343 (2011).","journal-title":"Annu Rev. Neurosci."},{"key":"1115_CR33","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1523\/JNEUROSCI.0232-09.2009","volume":"29","author":"SP Narayanan","year":"2009","unstructured":"Narayanan, S. P., Flores, A. I., Wang, F. & Macklin, W. B. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J. Neurosci. 29, 6860\u20136870 (2009).","journal-title":"J. Neurosci."},{"key":"1115_CR34","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1523\/JNEUROSCI.22-07-02451.2002","volume":"22","author":"FJ Sim","year":"2002","unstructured":"Sim, F. J., Zhao, C., Penderis, J. & Franklin, R. J. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 22, 2451\u20132459 (2002).","journal-title":"J. Neurosci."},{"key":"1115_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11312","volume":"7","author":"MB Keough","year":"2016","unstructured":"Keough, M. B. et al. An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination. Nat. Commun. 7, 11312 (2016).","journal-title":"Nat. Commun."},{"key":"1115_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2010.07.026","volume":"1351","author":"S Mozafari","year":"2010","unstructured":"Mozafari, S., Sherafat, M. A., Javan, M., Mirnajafi-Zadeh, J. & Tiraihi, T. Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Res. 1351, 50\u201356 (2010).","journal-title":"Brain Res."},{"key":"1115_CR37","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green, A. J. et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390, 2481\u20132489 (2017). A milestone for the remyelination field, this paper documented positive results from a randomized controlled trial of clemastine showing improved visual function in patients with MS who have chronic demyelinating optic neuropathy.","journal-title":"Lancet"},{"key":"1115_CR38","doi-asserted-by":"publisher","first-page":"e18246","DOI":"10.7554\/eLife.18246","volume":"5","author":"F Mei","year":"2016","unstructured":"Mei, F. et al. Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. eLife 5, e18246 (2016).","journal-title":"eLife"},{"key":"1115_CR39","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1073\/pnas.1714183114","volume":"114","author":"ID Duncan","year":"2017","unstructured":"Duncan, I. D., Marik, R. L., Broman, A. T. & Heidari, M. Thin myelin sheaths as the hallmark of remyelination persist over time and preserve axon function. Proc. Natl Acad. Sci. USA 114, 9685\u20139691 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR40","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/glia.20490","volume":"55","author":"DD Pearse","year":"2007","unstructured":"Pearse, D. D. et al. Transplantation of Schwann cells and\/or olfactory ensheathing glia into the contused spinal cord: survival, migration, axon association, and functional recovery. Glia 55, 976\u20131000 (2007).","journal-title":"Glia"},{"key":"1115_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuron.2016.05.016","volume":"91","author":"AS Saab","year":"2016","unstructured":"Saab, A. S. et al. Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 91, 119\u2013132 (2016).","journal-title":"Neuron"},{"key":"1115_CR42","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awn080","volume":"131","author":"KA Irvine","year":"2008","unstructured":"Irvine, K. A. & Blakemore, W. F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131, 1464\u20131477 (2008).","journal-title":"Brain"},{"key":"1115_CR43","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.24620","volume":"79","author":"B Bodini","year":"2016","unstructured":"Bodini, B. et al. Dynamic imaging of individual remyelination profiles in multiple sclerosis. Ann. Neurol. 79, 726\u2013738 (2016). The myelin-targeted in vivo human imaging here provided important proof of concept that remyelination correlated with functional recovery in MS.","journal-title":"Ann. Neurol."},{"key":"1115_CR44","doi-asserted-by":"publisher","first-page":"e700","DOI":"10.1212\/NXI.0000000000000700","volume":"7","author":"Y You","year":"2020","unstructured":"You, Y. et al. Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis. Neurol. Neuroimmunol. Neuroinflamm. 7, e700 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1115_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/NEJMoa010994","volume":"346","author":"A Chang","year":"2002","unstructured":"Chang, A., Tourtellotte, W. W., Rudick, R. & Trapp, B. D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346, 165\u2013173 (2002). This paper provided evidence that chronic lesions in MS are replete with premyelinating oligodendrocytes that seem to be stalled at the level of differentiation, a finding that has formed the basis for pro-differentiation approaches to remyelination.","journal-title":"N. Engl. J. Med."},{"key":"1115_CR46","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann, T. et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131, 1749\u20131758 (2008).","journal-title":"Brain"},{"key":"1115_CR47","doi-asserted-by":"publisher","first-page":"11807","DOI":"10.1073\/pnas.1808064115","volume":"115","author":"ID Duncan","year":"2018","unstructured":"Duncan, I. D. et al. The adult oligodendrocyte can participate in remyelination. Proc. Natl Acad. Sci. USA 115, 11807\u201311816 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","volume":"566","author":"MSY Yeung","year":"2019","unstructured":"Yeung, M. S. Y. et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature 566, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"1115_CR49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature14957","volume":"526","author":"J Samanta","year":"2015","unstructured":"Samanta, J. et al. Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature 526, 448\u2013452 (2015).","journal-title":"Nature"},{"key":"1115_CR50","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.stem.2010.04.002","volume":"6","author":"M Zawadzka","year":"2010","unstructured":"Zawadzka, M. et al. CNS-resident glial progenitor\/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6, 578\u2013590 (2010).","journal-title":"Cell Stem Cell"},{"key":"1115_CR51","doi-asserted-by":"publisher","first-page":"102015","DOI":"10.1016\/j.msard.2020.102015","volume":"41","author":"L Wooliscroft","year":"2020","unstructured":"Wooliscroft, L. et al. Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: a dose-ranging study with assessment of reliability of visual outcomes. Mult. Scler. Relat. Disord. 41, 102015 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1115_CR52","doi-asserted-by":"publisher","first-page":"e126329","DOI":"10.1172\/jci.insight.126329","volume":"4","author":"MD Hartley","year":"2019","unstructured":"Hartley, M. D. et al. Myelin repair stimulated by CNS-selective thyroid hormone action. JCI Insight 4, e126329 (2019).","journal-title":"JCI Insight"},{"key":"1115_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nn.2702","volume":"14","author":"JK Huang","year":"2011","unstructured":"Huang, J. K. et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 14, 45\u201353 (2011).","journal-title":"Nat. Neurosci."},{"key":"1115_CR54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","volume":"20","author":"JWL Brown","year":"2021","unstructured":"Brown, J. W. L. et al. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet Neurol. 20, 709\u2013720 (2021).","journal-title":"Lancet Neurol."},{"key":"1115_CR55","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/cns.13538","volume":"27","author":"M El-Etr","year":"2021","unstructured":"El-Etr, M., Akwa, Y., Rame, M., Schumacher, M. & Sitruk-Ware, R. Nestorone, a 19nor-progesterone derivative boosts remyelination in an animal model of demyelination. CNS Neurosci. Ther. 27, 464\u2013469 (2021).","journal-title":"CNS Neurosci. Ther."},{"key":"1115_CR56","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/nm1664","volume":"13","author":"S Mi","year":"2007","unstructured":"Mi, S. et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 13, 1228\u20131233 (2007).","journal-title":"Nat. Med."},{"key":"1115_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22452-0","volume":"8","author":"C Lu","year":"2018","unstructured":"Lu, C. et al. G-protein-coupled receptor Gpr17 regulates oligodendrocyte differentiation in response to lysolecithin-induced demyelination. Sci. Rep. 8, 4502 (2018).","journal-title":"Sci. Rep."},{"key":"1115_CR58","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.chembiol.2018.03.012","volume":"25","author":"N Merten","year":"2018","unstructured":"Merten, N. et al. Repurposing HAMI3379 to block GPR17 and promote rodent and human oligodendrocyte differentiation. Cell Chem. Biol. 25, 775\u2013786 e775 (2018).","journal-title":"Cell Chem. Biol."},{"key":"1115_CR59","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/1087057114559490","volume":"20","author":"JV Peppard","year":"2015","unstructured":"Peppard, J. V. et al. High-content phenotypic screening and triaging strategy to identify small molecules driving oligodendrocyte progenitor cell differentiation. J. Biomol. Screen 20, 382\u2013390 (2015).","journal-title":"J. Biomol. Screen"},{"key":"1115_CR60","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/jnr.22434","volume":"88","author":"L Joubert","year":"2010","unstructured":"Joubert, L. et al. Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J. Neurosci. Res. 88, 2546\u20132557 (2010).","journal-title":"J. Neurosci. Res."},{"key":"1115_CR61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh, V. A. et al. A regenerative approach to the treatment of multiple sclerosis. Nature 502, 327\u2013332 (2013). One of the earliest phenotypic screens for enhancing MBP+ oligodendrocytes from OPCs, this paper established many aspects of the now typical screening cascade.","journal-title":"Nature"},{"key":"1115_CR62","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei, F. et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat. Med. 20, 954\u2013960 (2014). This paper used micropillar plates as a novel phenotypic screening technology to measure \u2018myelination\u2019 in vitro and extensively characterized the pro-myelinating effects of clemastine.","journal-title":"Nat. Med."},{"key":"1115_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-2220-2","volume":"9","author":"KD Lariosa-Willingham","year":"2016","unstructured":"Lariosa-Willingham, K. D. et al. A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells. BMC Res. Notes 9, 419 (2016).","journal-title":"BMC Res. Notes"},{"key":"1115_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nbt.2561","volume":"31","author":"FJ Najm","year":"2013","unstructured":"Najm, F. J. et al. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat. Biotechnol. 31, 426\u2013433 (2013). The derivation and characterization of PSC-derived OPCs that retain the ability to differentiate to oligodendrocytes in vitro and in vivo is described in this paper.","journal-title":"Nat. Biotechnol."},{"key":"1115_CR65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.stemcr.2018.07.015","volume":"11","author":"MS Elitt","year":"2018","unstructured":"Elitt, M. S. et al. Chemical screening identifies enhancers of mutant oligodendrocyte survival and unmasks a distinct pathological phase in pelizaeus\u2013Merzbacher disease. Stem Cell Rep. 11, 711\u2013726 (2018).","journal-title":"Stem Cell Rep."},{"key":"1115_CR66","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm, F. J. et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522, 216\u2013220 (2015).","journal-title":"Nature"},{"key":"1115_CR67","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","volume":"560","author":"Z Hubler","year":"2018","unstructured":"Hubler, Z. et al. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature 560, 372\u2013376 (2018). This paper reported inhibition of specific cholesterol pathway enzymes and accumulation of 8,9-unsaturated sterols as a unifying \u2018off-target\u2019 mechanism by which many small molecules identified in phenotypic screens promote oligodendrocyte formation and remyelination.","journal-title":"Nature"},{"key":"1115_CR68","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/glia.23306","volume":"66","author":"YE Guo","year":"2018","unstructured":"Guo, Y. E., Suo, N., Cui, X., Yuan, Q. & Xie, X. Vitamin C promotes oligodendrocytes generation and remyelination. Glia 66, 1302\u20131316 (2018).","journal-title":"Glia"},{"key":"1115_CR69","doi-asserted-by":"publisher","unstructured":"Li, W. et al. High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells identifies novel targets. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.01.18.476755 (2022).","DOI":"10.1101\/2022.01.18.476755"},{"key":"1115_CR70","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neuron.2016.07.021","volume":"91","author":"SA Redmond","year":"2016","unstructured":"Redmond, S. A. et al. Somatodendritic expression of JAM2 inhibits oligodendrocyte myelination. Neuron 91, 824\u2013836 (2016).","journal-title":"Neuron"},{"key":"1115_CR71","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.cub.2015.07.056","volume":"25","author":"ME Bechler","year":"2015","unstructured":"Bechler, M. E., Byrne, L. & Ffrench-Constant, C. CNS myelin sheath lengths are an intrinsic property of oligodendrocytes. Curr. Biol. 25, 2411\u20132416 (2015).","journal-title":"Curr. Biol."},{"key":"1115_CR72","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1073\/pnas.1400140111","volume":"111","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Transcription factor induction of human oligodendrocyte progenitor fate and differentiation. Proc. Natl Acad. Sci. USA 111, 2885\u20132894 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1115_CR73","doi-asserted-by":"publisher","first-page":"103276","DOI":"10.1016\/j.ebiom.2021.103276","volume":"65","author":"A Manousi","year":"2021","unstructured":"Manousi, A. et al. Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence. EBioMedicine 65, 103276 (2021).","journal-title":"EBioMedicine"},{"key":"1115_CR74","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","volume":"15","author":"M Madhavan","year":"2018","unstructured":"Madhavan, M. et al. Induction of myelinating oligodendrocytes in human cortical spheroids. Nat. Methods 15, 700\u2013706 (2018).","journal-title":"Nat. Methods"},{"key":"1115_CR75","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1523\/JNEUROSCI.1493-16.2016","volume":"36","author":"F Mei","year":"2016","unstructured":"Mei, F. et al. Identification of the \u03ba-opioid receptor as a therapeutic target for oligodendrocyte remyelination. J. Neurosci. 36, 7925\u20137935 (2016).","journal-title":"J. Neurosci."},{"key":"1115_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/srep31599","volume":"6","author":"GA Gonzalez","year":"2016","unstructured":"Gonzalez, G. A. et al. Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system. Sci. Rep. 6, 31599 (2016).","journal-title":"Sci. Rep."},{"key":"1115_CR77","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1523\/JNEUROSCI.1530-18.2019","volume":"39","author":"KA Rankin","year":"2019","unstructured":"Rankin, K. A. et al. Selective estrogen receptor modulators enhance CNS remyelination independent of estrogen receptors. J. Neurosci. 39, 2184\u20132194 (2019).","journal-title":"J. Neurosci."},{"key":"1115_CR78","doi-asserted-by":"publisher","first-page":"e0189380","DOI":"10.1371\/journal.pone.0189380","volume":"12","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. PLoS ONE 12, e0189380 (2017).","journal-title":"PLoS ONE"},{"key":"1115_CR79","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","volume":"566","author":"S Jakel","year":"2019","unstructured":"Jakel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543\u2013547 (2019).","journal-title":"Nature"},{"key":"1115_CR80","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acs.jmedchem.5b01696","volume":"59","author":"Z Korade","year":"2016","unstructured":"Korade, Z. et al. The effect of small molecules on sterol homeostasis: measuring 7-dehydrocholesterol in Dhcr7-deficient Neuro2a cells and human fibroblasts. J. Med. Chem. 59, 1102\u20131115 (2016).","journal-title":"J. Med. Chem."},{"key":"1115_CR81","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1038\/s41596-019-0193-z","volume":"14","author":"C Muller","year":"2019","unstructured":"Muller, C., Junker, J., Bracher, F. & Giera, M. A gas chromatography\u2013mass spectrometry-based whole-cell screening assay for target identification in distal cholesterol biosynthesis. Nat. Protoc. 14, 2546\u20132570 (2019).","journal-title":"Nat. Protoc."},{"key":"1115_CR82","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/374559a0","volume":"374","author":"AG Byskov","year":"1995","unstructured":"Byskov, A. G. et al. Chemical structure of sterols that activate oocyte meiosis. Nature 374, 559\u2013562 (1995).","journal-title":"Nature"},{"key":"1115_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1039\/D1CB00145K","volume":"3","author":"MJ Pleshinger","year":"2022","unstructured":"Pleshinger, M. J. et al. Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formation. RSC Chem. Biol. 3, 56\u201368 (2022).","journal-title":"RSC Chem. Biol."},{"key":"1115_CR84","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.chembiol.2021.01.025","volume":"28","author":"Z Hubler","year":"2021","unstructured":"Hubler, Z. et al. Modulation of lanosterol synthase drives 24,25-epoxysterol synthesis and oligodendrocyte formation. Cell Chem. Biol. 28, 866\u2013875 (2021).","journal-title":"Cell Chem. Biol."},{"key":"1115_CR85","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1021\/acschembio.1c00461","volume":"16","author":"JL Sax","year":"2021","unstructured":"Sax, J. L., Hubler, Z., Allimuthu, D. & Adams, D. J. Screening reveals sterol derivatives with pro-differentiation, pro-survival, or potent cytotoxic effects on oligodendrocyte progenitor cells. ACS Chem. Biol. 16, 1288\u20131297 (2021).","journal-title":"ACS Chem. Biol."},{"key":"1115_CR86","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.chembiol.2019.01.004","volume":"26","author":"D Allimuthu","year":"2019","unstructured":"Allimuthu, D. et al. Diverse chemical scaffolds enhance oligodendrocyte formation by inhibiting CYP51, TM7SF2, or EBP. Cell Chem. Biol. 26, 593\u2013599 (2019).","journal-title":"Cell Chem. Biol."},{"key":"1115_CR87","doi-asserted-by":"publisher","unstructured":"Sax, J. L. et al. Enhancers of human and rodent oligodendrocyte formation predominantly induce cholesterol precursor accumulation. ACS Chem. Biol. https:\/\/doi.org\/10.1021\/acschembio.2c00330 (2022).","DOI":"10.1021\/acschembio.2c00330"},{"key":"1115_CR88","doi-asserted-by":"publisher","first-page":"e1091","DOI":"10.1212\/NXI.0000000000001091","volume":"8","author":"E Martin","year":"2021","unstructured":"Martin, E. Teriflunomide promotes oligodendroglial 8,9-unsaturated sterol accumulation and CNS remyelination. Neurol. Neuroimmunol. Neuroinflamm. 8, e1091 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1115_CR89","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.tins.2022.01.001","volume":"45","author":"SA Berghoff","year":"2022","unstructured":"Berghoff, S. A., Spieth, L. & Saher, G. Local cholesterol metabolism orchestrates remyelination. Trends Neurosci. 45, 272\u2013283 (2022). This recent review provides a broad perspective of multiple ways through which sterol synthesis, accumulation, and recycling contributes to myelin formation and remyelination.","journal-title":"Trends Neurosci."},{"key":"1115_CR90","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff, S. A. et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat. Neurosci. 24, 47\u201360 (2021).","journal-title":"Nat. Neurosci."},{"key":"1115_CR91","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri, L. et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science 359, 684\u2013688 (2018).","journal-title":"Science"},{"key":"1115_CR92","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1042\/bj1220751","volume":"122","author":"NL Banik","year":"1971","unstructured":"Banik, N. L. & Davison, A. N. Exchange of sterols between myelin and other membranes of developing rat brain. Biochem. J. 122, 751\u2013758 (1971).","journal-title":"Biochem. J."},{"key":"1115_CR93","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.neuron.2017.10.008","volume":"96","author":"MA Petersen","year":"2017","unstructured":"Petersen, M. A. et al. Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage. Neuron 96, 1003\u20131012 e1007 (2017).","journal-title":"Neuron"},{"key":"1115_CR94","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-019-1484-9","volume":"573","author":"M Segel","year":"2019","unstructured":"Segel, M. et al. Niche stiffness underlies the ageing of central nervous system progenitor cells. Nature 573, 130\u2013134 (2019).","journal-title":"Nature"},{"key":"1115_CR95","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","volume":"25","author":"B Neumann","year":"2019","unstructured":"Neumann, B. et al. Metformin restores CNS remyelination capacity by rejuvenating aged stem cells. Cell Stem Cell 25, 473\u2013485 e478 (2019).","journal-title":"Cell Stem Cell"},{"key":"1115_CR96","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00401-020-02129-7","volume":"139","author":"KS Rawji","year":"2020","unstructured":"Rawji, K. S. et al. Niacin-mediated rejuvenation of macrophage\/microglia enhances remyelination of the aging central nervous system. Acta Neuropathol. 139, 893\u2013909 (2020).","journal-title":"Acta Neuropathol."},{"key":"1115_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18744-6","volume":"8","author":"D Espinosa-Hoyos","year":"2018","unstructured":"Espinosa-Hoyos, D. et al. Engineered 3D-printed artificial axons. Sci. Rep. 8, 478 (2018).","journal-title":"Sci. Rep."},{"key":"1115_CR98","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"1115_CR99","doi-asserted-by":"publisher","first-page":"e35136","DOI":"10.7554\/eLife.35136","volume":"7","author":"JJ Early","year":"2018","unstructured":"Early, J. J. An automated high-resolution in vivo screen in zebrafish to identify chemical regulators of myelination. eLife 7, e35136 (2018).","journal-title":"eLife"},{"key":"1115_CR100","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/molecules18044002","volume":"18","author":"J Acimovic","year":"2013","unstructured":"Acimovic, J. & Rozman, D. Steroidal triterpenes of cholesterol synthesis. Molecules 18, 4002\u20134017 (2013).","journal-title":"Molecules"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01115-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T01:34:32Z","timestamp":1700962472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01115-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1038\/s41589-022-01115-2","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: D.J.A. is a founder, consultant, director, and shareholder of Convelo Therapeutics, which seeks to develop remyelinating therapeutics. D.J.A., is an inventor on patents and patent applications that have been licensed to Convelo. A.V.C. is an employee of Convelo Therapeutics. Convelo has not provided any support to the Adams Lab.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}